Kinexus Announces the Launch of New Peptide Productio... (dition to a unique integrated suite of p...)

Kinexus Announces the Launch of New Peptide Production Services

Date:3/16/2010

dition to a unique integrated suite of proteomics services offered by Kinexus which delivers solutions and services for pharmaceutical, biotechnology, academic, life science, clinical and government research laboratories from around the world.

To learn more about the new Peptide Production Services or any of the other proteomics services available, please visit www.kinexus.ca. Kinexus Bioinformatics Corporation is a privately held, biotechnology company engaged in the research and development of innovative methods to understand the relationships of signaling proteins in molecular communication networks. The application of this knowledge positions Kinexus and its clients in drug development, rational drug design, disease diagnosis and personalized therapies to improve human health.

SOURCE Kinexus Bioinformatics Corporation

SOURCE Kinexus Bioinformatics Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Kinexus Announces the Launch of a New Protein Kinase Microarray
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line

Post Your Comments:

(Date:5/20/2013)... , May 20, 2013 Cempra, ... on developing differentiated antibiotics to meet critical medical ... announced that it presented data at the American ... Philadelphia demonstrating the antibacterial and ... Cempra,s prior Phase 2 clinical trial in outpatients ...

(Date:5/20/2013)... 20, 2013 Recognizing exciting and ... members to its 2013 Class of Young Professors. ... will provide this outstanding international group with more ... basic science to meet global challenges. , The ... promising young and untenured research faculty working in ...

(Date:5/19/2013)... Switzerland’s MS Tûranor PlanetSolar , the ... record for a transatlantic crossing by a solar electric ... 25, 2013, the solar powered boat sailed 2,867miles (5,310 ... of 5.3 knots before reaching Marigot, St. Martin, in ... first-of-its-kind catamaran completed this year’s passage across the Atlantic ...

(Date:5/17/2013)... rejection occurs when the transplant recipient,s immune system identifies ... It was previously thought that T cells, the immune ... molecules known as chemokines in order to migrate to ... Journal of Clinical Investigation , Fadi Lakkis and colleagues ... that chemokine stimulation of T cells is not required ...

Breaking Biology Technology:Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2 DuPont Celebrates Scientific Innovation by Recognizing Young Professors 2 DuPont Celebrates Scientific Innovation by Recognizing Young Professors 3 MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 2 MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 3 MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 4 MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 5 MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 6

[0] Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP)[0] DuPont Celebrates Scientific Innovation by Recognizing Young Professors [0] MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel [0] Researchers identify signals that direct the immune system to reject a transplanted organ

... LEUVEN, Belgium, August 27 ThromboGenics NV,(Euronext Brussels: THR), a ... for eye disease, vascular disease,and cancer, is today issuing a ... period ending 30 June, 2009. , ... which,are key to its aim of becoming a profitable, integrated ...

... Massachusetts and CHEADLE, England, August 27 ,Cardea Technology, ... and configure their software tools for Vertebral Fracture,Assessment, ... on bone,densitometers, to exchange information and create reports ... Optasia Medical Ltd. has developed SpineAnalyzer(TM), a ...

... , , ATLANTA, Aug. 27 ... million extension of its Series C financing which was originally completed in ... $5 million in Series C preferred stock received warrants for an additional ... have up to 30 days from the delivery of Phase III top-line ...

ThromboGenics NV Announces Business Update and Half Year Results 2009 Cardea Technology Inc and Optasia Medical Ltd Announce Plans to Collaborate to Optimize Their Vertebral Fracture Assessment Tools Alimera Sciences Closes $5 Million in Extended Series C Financing

(Date:5/18/2013)... presented at Digestive Disease Week (DDW) explores new ... lifestyle. , Individuals suffering from Crohn,s disease ... and poor quality of life. These symptoms can ... randomized, double blind, placebo-controlled study found for the ... significant relief of these symptoms. , "Our ...

(Date:5/17/2013)... Atlanta residents of all ages will celebrate the ... impact on our daily lives during the inaugural ... engineers and educators from local museums, corporations, K-12 ... than 40 different events for children and adults ... http://atlantasciencefestival.org . , The annual Atlanta ...

(Date:5/17/2013)... The Federation of American Societies for Experimental Biology ... Institutes of Health (NIH) funding trends highlighting the devastating ... critical research. The FASEB analysis follows a May 15th ... MD, PhD, who testified that the $1.6 billion cut ... is "having a substantial impact on the scientific community." ...

Breaking Biology News(10 mins):Research examines new methods for managing digestive health 2 Research examines new methods for managing digestive health 3 First Atlanta Science Festival set for 2014 2

[0] Research examines new methods for managing digestive health [0] First Atlanta Science Festival set for 2014 [0] New FASEB analysis documents impact of budget cuts on biomedical research

... A University of Leicester archaeologist has discovered a ... Staffordshire - believed to be the earliest archaeological evidence ... As reported in Post-Medieval Archaeology (volume 44/1) ... significance of the find is in the insights it ...

... your wedge may not help much, but mixing in longer ... studies have shown that variable practice improves the brain,s memory ... task. Cognitive neuroscientists at USC and UCLA describe the neural ... Nature Neuroscience . The researchers split 59 volunteers ...

... for regulating viruses that has worked its way into ... adult and fetal hemoglobin production, Medical College of Georgia ... to more targeted therapies for sickle cell patients whose ... throughout the body. Fetal hemoglobin, on the other ...

Cached Biology News:Archaeology find sheds new light on family pets 2 Why (smart) practice makes perfect 2 Modulator of fetal hemoglobin switch may target sickle cell disease 2 Modulator of fetal hemoglobin switch may target sickle cell disease 3

Archaeology find sheds new light on family pets Why (smart) practice makes perfect Modulator of fetal hemoglobin switch may target sickle cell disease

MOUSE ANTI HUMAN CYTOKERATIN 1-8...

GOAT ANTI HUMAN PSA (ISOFORM 1)...

... Immunogen: Synthetic peptide derived from the N-terminal ... ZO-1. Specificity: Specific for the N-terminus ... Reactivity: Human Dog Rat Mouse (positive controls: ... mouse liver heart blood vessel and brain ...

p-Raf-1 (Ser 338/Tyr 341)-R...

Biology Products:

Mouse Anti-Human CYTOKERATIN 1-8 Monoclonal Antibody, Unconjugated, Clone Ks1-8 from AbD Serotec Goat Anti-Human PSA (Isoform 1) Polyclonal Antibody, Unconjugated from AbD Serotec Rabbit Anti-ZO-1 (N-term) Monoclonal Antibody, Clone ZMD.437 from Invitrogen Rabbit Anti-Raf-1, phospho (Ser338 / Tyr341) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.